11 reports

Pharmaceutical: The pharmaceutical segment includes products for areas such as anti-infective, antipsychotic, contraceptive, hematology, gastrointestinal, immunology, infectious diseases, oncology, neurology, pain management, thrombosis, and JOHNSON & JOHNSON BUSINESS OVERVIEW Source: T

  • Smoking Cessation
  • United States
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG

gastrointestinal and urinary conditions, and arthritis EVOTEC GAMUCCI JAPAN TOBACCO LOGIC TECHNOLOGY NICOTEK NOVARTIS Company REVOLYMER Description TARGET THE HARVARD DRUG GROUP Retailing company based in the US Designs, develops, and formulates polymers in the UK, Canada, Germany, Italy, a

  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Lack of exercise and sedentary lifestyles have caused not only weight gain but also gastrointestinal problems.

  • OTC
  • Smoking Cessation
  • Russian Federation
  • Demand

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Healthcare
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative

The most common adverse events reported in the Phase I clinical trials were related to the central nervous system and the gastrointestinal system.

  • Pharmaceutical
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative

It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women' s health issues, orphan diseases and genitourina

  • Smoking Cessation
  • United States
  • Company
  • Product Initiative
  • Omeros Corporation

Its products find application in the therapeutic areas of gastrointestinal, cardiovascular, respiratory system, central nervous system, anti-infectives, oncology, allergy and immune system, dermatology, and others.

  • Smoking Cessation
  • United States
  • Company
  • Company Financials
  • Orexigen Therapeutics, Inc.

gastrointestinal disorders and irritable bowel syndrome. ##-Feb-2017 Addex Therapeutics announced that it has raised gross proceeds of CHF ##. ## million through a private placement in which ##. ## million treasury shares were placed at CHF## per share.

  • OTC
  • Psychotic Disorder
  • Smoking Cessation
  • Therapy
  • Addex Therapeutics Ltd
  • Small Molecules to Antagonize CHRNA4 and CHRNB2 for Nicotine Addiction

gastrointestinal disorders and irritable bowel syndrome. ##-Feb-2017 Addex Therapeutics announced that it has raised gross proceeds of CHF ##. ## million through a private placement in which ##. ## million treasury shares were placed at CHF## per share.

  • OTC
  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • SMOKING CESSATION - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2015
  • SMOKING CESSATION - PIPELINE BY JOHNSON & JOHNSON, H2 2015

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • United States
  • Product Initiative
  • SMOKING CESSATION - PIPELINE BY JOHNSON & JOHNSON, H1 2015
  • SMOKING CESSATION - PIPELINE BY PFIZER INC., H1 2015

The most common adverse events reported in the Phase I clinical trials were related to the central nervous system and the gastrointestinal system.

  • Pharmaceutical
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative